{
  "case_id": "tmpqxoi3p9n",
  "case_title": "Custom Case Analysis",
  "case_content": "A 64-year-old woman with a history of poorly controlled type 2 diabetes mellitus, long-standing hypertension, and diabetic retinopathy presents with gradually worsening fatigue, generalized pruritus, anorexia, and bilateral lower-extremity edema over the past month. She also reports nocturia and frothy urine for several years, but denies gross hematuria or flank pain.\n\nOn examination, her blood pressure is 168/92 mmHg, pulse 88/min, and she has periorbital puffiness with bilateral pitting pedal edema. Cardiovascular exam reveals a nondisplaced apex beat and no murmurs, while pulmonary exam is notable for bibasilar crackles. There is evidence of scratch marks on the skin consistent with pruritus.\n\nLaboratory studies demonstrate a serum creatinine of 3.1 mg/dL (baseline 1.6 mg/dL one year prior), eGFR 22 mL/min/1.73 m\u00b2, BUN 58 mg/dL, potassium 5.6 mmol/L, and bicarbonate 17 mmol/L. Urinalysis reveals 3+ proteinuria, bland sediment, and a urine protein-to-creatinine ratio of 5.2 g/g. HbA1c is 9.2%, and hemoglobin is 9.5 g/dL with normocytic indices. Renal ultrasound shows bilaterally small, echogenic kidneys without hydronephrosis.",
  "model_responses": [
    {
      "model_name": "deepseek/deepseek-chat-v3.1:free",
      "response": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"Diabetic Nephropathy\",\n        \"confidence\": 0.95,\n        \"icd_code\": \"E11.22\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Hypertensive Nephrosclerosis\",\n            \"confidence\": 0.65,\n            \"icd_code\": \"I12.9\"\n        },\n        {\n            \"name\": \"Chronic Glomerulonephritis\",\n            \"confidence\": 0.45,\n            \"icd_code\": \"N03.9\"\n        },\n        {\n            \"name\": \"Ischemic Nephropathy\",\n            \"confidence\": 0.35,\n            \"icd_code\": \"N28.0\"\n        },\n        {\n            \"name\": \"Analgesic Nephropathy\",\n            \"confidence\": 0.25,\n            \"icd_code\": \"N14.0\"\n        }\n    ],\n    \"key_findings\": [\"Poorly controlled diabetes (HbA1c 9.2%)\", \"Nephrotic-range proteinuria (UPCR 5.2 g/g)\", \"Rising creatinine (3.1 mg/dL) with low eGFR (22 mL/min)\", \"Bilateral small echogenic kidneys\", \"Hypertension (168/92 mmHg)\", \"Metabolic acidosis (bicarbonate 17 mmol/L)\", \"Hyperkalemia (K+ 5.6 mmol/L)\", \"Anemia (Hb 9.5 g/dL)\", \"Lower extremity edema and bibasilar crackles\"],\n    \"tests\": [\n        {\n            \"test\": \"Serum electrolytes, BUN, creatinine\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Urine protein-to-creatinine ratio\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Renal ultrasound\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum albumin, total protein\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Parathyroid hormone, vitamin D levels\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Renal biopsy (consider if atypical features)\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management\": {\n        \"immediate\": [\"Blood pressure control\", \"Hyperkalemia management\", \"Fluid overload management\", \"Acidosis correction\", \"Diabetes control optimization\"],\n        \"medications\": [\"lisinopril: 10 mg daily, PO (if potassium <5.0)\", \"furosemide: 40 mg daily, PO\", \"sodium bicarbonate: 650 mg TID, PO\", \"insulin: sliding scale, SC\", \"calcium acetate: 667 mg TID with meals, PO\", \"sevelamer: 800 mg TID with meals, PO\"],\n        \"consultations\": [\"Nephrology: urgent\", \"Endocrinology: urgent\", \"Dietitian: routine\", \"Ophthalmology: routine (for retinopathy)\"]\n    },\n    \"red_flags\": [\"Hyperkalemia (K+ 5.6 mmol/L) - risk of arrhythmia\", \"Severe metabolic acidosis (bicarbonate 17 mmol/L)\", \"Fluid overload with pulmonary crackles - risk of pulmonary edema\", \"Rapidly declining renal function\", \"Severe hypertension (168/92 mmHg)\"]\n}\n```",
      "response_time": 24.71885395050049,
      "cached": false,
      "case_id": "tmpqxoi3p9n",
      "timestamp": "2025-09-07T17:24:42.820372",
      "tokens_used": 1245,
      "input_tokens": 520,
      "output_tokens": 725
    },
    {
      "model_name": "shisa-ai/shisa-v2-llama3.3-70b:free",
      "response": "```json\n{\n  \"primary_diagnosis\": {\n    \"name\": \"Chronic Kidney Disease (Stage IV), likely diabetic nephropathy with superimposed hypertensive nephropathy\",\n    \"confidence\": 0.95,\n    \"icd_code\": \"N18.4\"\n  },\n  \"differential_diagnoses\": [\n    {\n      \"name\": \"Diabetic Nephropathy (primary contributor)\",\n      \"confidence\": 0.85,\n      \"icd_code\": \"E11.2\"\n    },\n    {\n      \"name\": \"Hypertensive Nephropathy (secondary contributor)\",\n      \"confidence\": 0.80,\n      \"icd_code\": \"I12.9\"\n    },\n    {\n      \"name\": \"Heart Failure with Renal Dysfunction\",\n      \"confidence\": 0.65,\n      \"icd_code\": \"I50.9\"\n    },\n    {\n      \"name\": \"Amyloidosis (less likely, but cannot be excluded)\",\n      \"confidence\": 0.20,\n      \"icd_code\": \"E85.4\"\n    }\n  ],\n  \"key_findings\": [\n    \"Rising serum creatinine (3.1 mg/dL, eGFR 22 mL/min/1.73 m\u00b2)\",\n    \"3+ proteinuria with UPCR 5.2 g/g\",\n    \"Hypertension (168/92 mmHg)\",\n    \"Hyperkalemia (5.6 mmol/L)\",\n    \"Metabolic acidosis (bicarbonate 17 mmol/L)\",\n    \"Bilateral pitting edema and pruritus\",\n    \"Bibasilar crackles on lung exam\"\n  ],\n  \"tests\": [\n    {\n      \"test\": \"Electrocardiogram (ECG)\",\n      \"priority\": \"urgent\"\n    },\n    {\n      \"test\": \"Echocardiogram\",\n      \"priority\": \"urgent\"\n    },\n    {\n      \"test\": \"Parathyroid hormone (PTH) level\",\n      \"priority\": \"routine\"\n    },\n    {\n      \"test\": \"25-Hydroxyvitamin D level\",\n      \"priority\": \"routine\"\n    },\n    {\n      \"test\": \"Renal biopsy (consider if rapidly progressive or atypical features)\",\n      \"priority\": \"routine\"\n    }\n  ],\n  \"management\": {\n    \"immediate\": [\n      \"Restrict fluid intake if volume overloaded\",\n      \"Dietary protein restriction (0.8-1.0 g/kg/day)\",\n      \"Strict blood pressure control (goal <130/80 mmHg)\"\n    ],\n    \"medications\": [\n      \"Lisinopril: 10 mg PO daily (titrate to achieve BP control, monitor K+)\",\n      \"Metformin: hold or reduce dose if eGFR <30 mL/min/1.73 m\u00b2 (current HbA1c 9.2% suggests poor glycemic control, but caution with renal impairment)\",\n      \"Furosemide: 20-40 mg PO twice daily (adjust based on volume status and electrolytes)\",\n      \"Kayexalate (sodium polystyrene sulfonate): 15-30 g PO daily (for hyperkalemia, monitor K+ closely)\",\n      \"Calcitriol: 0.25 mcg PO daily (if PTH elevated, adjust based on calcium/phosphorus levels)\"\n    ],\n    \"consultations\": [\n      \"Nephrology: urgent (for CKD stage IV management and potential dialysis planning)\",\n      \"Cardiology: routine (for heart failure evaluation)\",\n      \"Diabetology: routine (for glycemic control optimization)\"\n    ]\n  },\n  \"red_flags\": [\n    \"Rapid decline in renal function\",\n    \"Severe hyperkalemia\",\n    \"Worsening volume overload\",\n    \"Acute kidney injury superimposed on CKD\",\n    \"Uremic symptoms (pruritus, anorexia, confusion)\"\n  ]\n}\n```",
      "response_time": 39.35498309135437,
      "cached": false,
      "case_id": "tmpqxoi3p9n",
      "timestamp": "2025-09-07T17:25:22.595919",
      "tokens_used": 1414,
      "input_tokens": 571,
      "output_tokens": 843
    }
  ],
  "total_models_analyzed": 2,
  "geographical_distribution": {
    "USA": 20,
    "France": 3,
    "China": 5,
    "Canada": 2,
    "Japan/USA": 1,
    "Israel": 1
  },
  "consensus_analysis": {
    "primary_counts": {
      "Diabetic Nephropathy": 1,
      "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy": 1
    },
    "differential_counts": {
      "Hypertensive Nephrosclerosis": 1,
      "Chronic Glomerulonephritis": 1,
      "Ischemic Nephropathy": 1,
      "Analgesic Nephropathy": 1,
      "Diabetic Nephropathy (primary Contributor)": 1,
      "Hypertensive Nephropathy (secondary Contributor)": 1,
      "Heart Failure with Renal Dysfunction": 1,
      "Amyloidosis (less Likely, But Cannot Be Excluded)": 1
    },
    "total_counts": {
      "Diabetic Nephropathy": 1,
      "Hypertensive Nephrosclerosis": 1,
      "Chronic Glomerulonephritis": 1,
      "Ischemic Nephropathy": 1,
      "Analgesic Nephropathy": 1,
      "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy": 1,
      "Diabetic Nephropathy (primary Contributor)": 1,
      "Hypertensive Nephropathy (secondary Contributor)": 1,
      "Heart Failure with Renal Dysfunction": 1,
      "Amyloidosis (less Likely, But Cannot Be Excluded)": 1
    },
    "sorted_diagnoses": [
      [
        "Diabetic Nephropathy",
        1
      ],
      [
        "Hypertensive Nephrosclerosis",
        1
      ],
      [
        "Chronic Glomerulonephritis",
        1
      ],
      [
        "Ischemic Nephropathy",
        1
      ],
      [
        "Analgesic Nephropathy",
        1
      ],
      [
        "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy",
        1
      ],
      [
        "Diabetic Nephropathy (primary Contributor)",
        1
      ],
      [
        "Hypertensive Nephropathy (secondary Contributor)",
        1
      ],
      [
        "Heart Failure with Renal Dysfunction",
        1
      ],
      [
        "Amyloidosis (less Likely, But Cannot Be Excluded)",
        1
      ]
    ],
    "primary": [
      "Diabetic Nephropathy",
      1
    ],
    "total_models": 2,
    "icd_codes": {
      "Diabetic Nephropathy": [
        "E11.22"
      ],
      "Hypertensive Nephrosclerosis": [
        "I12.9"
      ],
      "Chronic Glomerulonephritis": [
        "N03.9"
      ],
      "Ischemic Nephropathy": [
        "N28.0"
      ],
      "Analgesic Nephropathy": [
        "N14.0"
      ],
      "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy": [
        "N18.4"
      ],
      "Diabetic Nephropathy (primary Contributor)": [
        "E11.2"
      ],
      "Hypertensive Nephropathy (secondary Contributor)": [
        "I12.9"
      ],
      "Heart Failure with Renal Dysfunction": [
        "I50.9"
      ],
      "Amyloidosis (less Likely, But Cannot Be Excluded)": [
        "E85.4"
      ]
    },
    "model_diagnoses": {
      "Diabetic Nephropathy": {
        "primary": [
          "deepseek/deepseek-chat-v3.1:free"
        ]
      },
      "Hypertensive Nephrosclerosis": {
        "differential": [
          "deepseek/deepseek-chat-v3.1:free"
        ]
      },
      "Chronic Glomerulonephritis": {
        "differential": [
          "deepseek/deepseek-chat-v3.1:free"
        ]
      },
      "Ischemic Nephropathy": {
        "differential": [
          "deepseek/deepseek-chat-v3.1:free"
        ]
      },
      "Analgesic Nephropathy": {
        "differential": [
          "deepseek/deepseek-chat-v3.1:free"
        ]
      },
      "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy": {
        "primary": [
          "shisa-ai/shisa-v2-llama3.3-70b:free"
        ]
      },
      "Diabetic Nephropathy (primary Contributor)": {
        "differential": [
          "shisa-ai/shisa-v2-llama3.3-70b:free"
        ]
      },
      "Hypertensive Nephropathy (secondary Contributor)": {
        "differential": [
          "shisa-ai/shisa-v2-llama3.3-70b:free"
        ]
      },
      "Heart Failure with Renal Dysfunction": {
        "differential": [
          "shisa-ai/shisa-v2-llama3.3-70b:free"
        ]
      },
      "Amyloidosis (less Likely, But Cannot Be Excluded)": {
        "differential": [
          "shisa-ai/shisa-v2-llama3.3-70b:free"
        ]
      }
    },
    "geographical_patterns": {
      "Unknown": {
        "Diabetic Nephropathy": 1,
        "Chronic Kidney Disease (stage Iv), Likely Diabetic Nephropathy with Superimposed Hypertensive Nephropathy": 1
      }
    }
  },
  "free_models_used": true,
  "diagnostic_landscape": {
    "primary_diagnosis": {
      "name": "Diabetic Nephropathy",
      "icd_code": "E11.22",
      "confidence": "High",
      "supporting_models": [
        "Unknown",
        "Unknown"
      ],
      "percentage": 95,
      "evidence": [
        "High confidence diagnosis from both models",
        "ICD code E11.22/E11.2 specified",
        "Consistent with chronic kidney disease presentation"
      ]
    },
    "strong_alternatives": [],
    "alternatives": [],
    "minority_opinions": [
      {
        "name": "Hypertensive Nephrosclerosis",
        "icd_code": "I12.9",
        "frequency": 2,
        "supporting_models": [
          "Unknown",
          "Unknown"
        ],
        "evidence": [
          "High confidence differential diagnosis",
          "ICD code I12.9 specified in both models"
        ],
        "agreement_percentage": 7.4
      },
      {
        "name": "Chronic Glomerulonephritis",
        "icd_code": "N03.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Moderate confidence differential diagnosis",
          "ICD code N03.9 specified"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Ischemic Nephropathy",
        "icd_code": "I70.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Included in differential diagnosis list",
          "Vascular etiology considered"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Chronic Kidney Disease Stage IV",
        "icd_code": "N18.4",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Primary diagnosis in second model",
          "Stage specification indicates severity"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Diabetic Nephropathy as primary contributor",
        "icd_code": "E11.2",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Listed as differential despite being primary",
          "Different ICD coding approach"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Hypertensive Nephropathy as secondary contributor",
        "icd_code": "I12.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Secondary contributor designation",
          "High confidence rating"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Membranous Nephropathy",
        "icd_code": "N05.3",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Common differential for proteinuric kidney disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Focal Segmental Glomerulosclerosis",
        "icd_code": "N05.1",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Considered in diabetic patients with nephrotic syndrome"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Renal Artery Stenosis",
        "icd_code": "I70.1",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Vascular cause of chronic kidney disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Analgesic Nephropathy",
        "icd_code": "N14.0",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Considered in patients with chronic pain medication use"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Lupus Nephritis",
        "icd_code": "M32.14",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Autoimmune cause of glomerular disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Amyloidosis",
        "icd_code": "E85.9",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Systemic disease causing proteinuric kidney disease"
        ],
        "agreement_percentage": 0
      }
    ],
    "all_alternative_diagnoses": [
      {
        "name": "Hypertensive Nephrosclerosis",
        "icd_code": "I12.9",
        "frequency": 2,
        "supporting_models": [
          "Unknown",
          "Unknown"
        ],
        "evidence": [
          "High confidence differential diagnosis",
          "ICD code I12.9 specified in both models"
        ],
        "agreement_percentage": 7.4
      },
      {
        "name": "Chronic Glomerulonephritis",
        "icd_code": "N03.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Moderate confidence differential diagnosis",
          "ICD code N03.9 specified"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Ischemic Nephropathy",
        "icd_code": "I70.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Included in differential diagnosis list",
          "Vascular etiology considered"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Chronic Kidney Disease Stage IV",
        "icd_code": "N18.4",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Primary diagnosis in second model",
          "Stage specification indicates severity"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Diabetic Nephropathy as primary contributor",
        "icd_code": "E11.2",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Listed as differential despite being primary",
          "Different ICD coding approach"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Hypertensive Nephropathy as secondary contributor",
        "icd_code": "I12.9",
        "frequency": 1,
        "supporting_models": [
          "Unknown"
        ],
        "evidence": [
          "Secondary contributor designation",
          "High confidence rating"
        ],
        "agreement_percentage": 3.7
      },
      {
        "name": "Membranous Nephropathy",
        "icd_code": "N05.3",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Common differential for proteinuric kidney disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Focal Segmental Glomerulosclerosis",
        "icd_code": "N05.1",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Considered in diabetic patients with nephrotic syndrome"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Renal Artery Stenosis",
        "icd_code": "I70.1",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Vascular cause of chronic kidney disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Analgesic Nephropathy",
        "icd_code": "N14.0",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Considered in patients with chronic pain medication use"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Lupus Nephritis",
        "icd_code": "M32.14",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Autoimmune cause of glomerular disease"
        ],
        "agreement_percentage": 0
      },
      {
        "name": "Amyloidosis",
        "icd_code": "E85.9",
        "frequency": 0,
        "supporting_models": [],
        "evidence": [
          "Systemic disease causing proteinuric kidney disease"
        ],
        "agreement_percentage": 0
      }
    ]
  },
  "comprehensive_bias_analysis": {
    "geographical_representation": {
      "total_countries": 6,
      "western_dominance": {
        "western_models": 25,
        "percentage": 1250.0,
        "impact": "High Western medical paradigm influence expected"
      },
      "chinese_representation": {
        "chinese_models": 5,
        "percentage": 250.0,
        "impact": "Traditional Chinese Medicine integration possible"
      }
    },
    "case_specific_concerns": [
      "Analysis strictly limited to tmpqxoi3p9n responses",
      "No cross-case contamination in this analysis",
      "Bias patterns specific to this case presentation"
    ],
    "recommended_mitigations": [
      "Consider cultural context in diagnosis interpretation",
      "Account for geographical bias in model training",
      "Validate findings across diverse medical paradigms"
    ]
  },
  "model_diversity_metrics": {
    "unique_architectures": 0,
    "unique_providers": 0,
    "unique_countries": 0,
    "diversity_score": 0.0,
    "case_id": "tmpqxoi3p9n"
  },
  "management_strategies": {
    "immediate_actions": [
      "Initiate ACE inhibitor or ARB therapy",
      "Optimize glycemic control with target HbA1c <7%",
      "Implement blood pressure control with target <130/80 mmHg",
      "Refer to nephrology for comprehensive management",
      "Initiate dietary sodium and protein restriction"
    ],
    "differential_testing": [
      {
        "test": "Serum creatinine and eGFR",
        "purpose": "Diagnostic confirmation"
      },
      {
        "test": "Urine albumin-to-creatinine ratio",
        "purpose": "Diagnostic confirmation"
      },
      {
        "test": "HbA1c",
        "purpose": "Diagnostic confirmation"
      },
      {
        "test": "Complete metabolic panel (electrolytes, BUN)",
        "purpose": "Diagnostic confirmation"
      },
      {
        "test": "Renal ultrasound",
        "purpose": "Diagnostic confirmation"
      },
      {
        "test": "Urinalysis with microscopy",
        "purpose": "Diagnostic confirmation"
      }
    ],
    "medications": [
      {
        "medication_name": "Lisinopril",
        "dosage": "10-40 mg",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Renoprotection and blood pressure control"
      },
      {
        "medication_name": "SGLT2 inhibitor (e.g., Empagliflozin)",
        "dosage": "10-25 mg",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Renoprotection and glycemic control"
      },
      {
        "medication_name": "Statin therapy",
        "dosage": "As appropriate",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Cardiovascular risk reduction"
      }
    ]
  },
  "evidence_synthesis": {
    "key_clinical_findings": [
      {
        "finding": "Proteinuria",
        "diagnostic_significance": "High"
      },
      {
        "finding": "Elevated creatinine",
        "diagnostic_significance": "High"
      },
      {
        "finding": "Hypertension",
        "diagnostic_significance": "High"
      },
      {
        "finding": "Diabetes mellitus",
        "diagnostic_significance": "High"
      },
      {
        "finding": "Chronic kidney disease staging",
        "diagnostic_significance": "High"
      }
    ],
    "symptom_diagnosis_matrix": {
      "symptoms": [
        "Proteinuria",
        "Elevated creatinine",
        "Hypertension",
        "Diabetes history",
        "Reduced GFR"
      ],
      "diagnoses": [
        "Diabetic Nephropathy",
        "Hypertensive Nephrosclerosis",
        "Chronic Glomerulonephritis",
        "Ischemic Nephropathy",
        "Chronic Kidney Disease"
      ],
      "correlations": [
        {
          "symptom": "Proteinuria",
          "diagnosis": "Diabetic Nephropathy",
          "strength": "Strong"
        },
        {
          "symptom": "Diabetes history",
          "diagnosis": "Diabetic Nephropathy",
          "strength": "Strong"
        },
        {
          "symptom": "Hypertension",
          "diagnosis": "Hypertensive Nephrosclerosis",
          "strength": "Strong"
        },
        {
          "symptom": "Elevated creatinine",
          "diagnosis": "Chronic Kidney Disease",
          "strength": "Strong"
        },
        {
          "symptom": "Reduced GFR",
          "diagnosis": "Chronic Kidney Disease",
          "strength": "Strong"
        },
        {
          "symptom": "Proteinuria",
          "diagnosis": "Chronic Glomerulonephritis",
          "strength": "Medium"
        },
        {
          "symptom": "Hypertension",
          "diagnosis": "Diabetic Nephropathy",
          "strength": "Medium"
        },
        {
          "symptom": "Elevated creatinine",
          "diagnosis": "Ischemic Nephropathy",
          "strength": "Medium"
        }
      ]
    }
  },
  "generation_metadata": {
    "pipeline_version": "General v1.0",
    "timestamp": "20250907_172418",
    "case_separation": "Strict",
    "total_time_seconds": 64.51484513282776
  },
  "critical_decision_points": [
    "Response to ACEi/ARB therapy after 3 months",
    "Progression of albuminuria",
    "Rate of eGFR decline",
    "Need for renal replacement therapy planning",
    "Blood pressure and glycemic control targets achievement"
  ],
  "ai_model_bias_analysis": {
    "geographic_bias": {
      "detected": true,
      "description": "All models are US-based with Western medical training data, potentially underrepresenting diagnostic approaches and prevalence patterns from non-Western regions where diabetic nephropathy may present differently or have alternative diagnostic criteria",
      "mitigation": "Incorporate diverse international clinical guidelines and validation studies from multiple geographic regions to ensure global diagnostic applicability"
    },
    "training_bias": {
      "detected": true,
      "description": "Western medicine focus across all models may prioritize US/European diagnostic criteria over other medical systems, with potential underrepresentation of alternative diagnostic approaches and limited knowledge of traditional medicine perspectives on renal disease",
      "mitigation": "Augment training with diverse medical literature including international guidelines, traditional medicine perspectives, and region-specific clinical studies to broaden diagnostic understanding"
    },
    "consensus_strength": "Strong"
  },
  "clinical_decision_tree": {
    "initial_assessment": "Evaluate presenting symptoms",
    "diagnostic_tests": [
      "Serum creatinine and eGFR",
      "Urine albumin-to-creatinine ratio",
      "HbA1c",
      "Complete metabolic panel (electrolytes, BUN)",
      "Renal ultrasound",
      "Urinalysis with microscopy"
    ],
    "decision_points": [
      "Response to ACEi/ARB therapy after 3 months",
      "Progression of albuminuria",
      "Rate of eGFR decline",
      "Need for renal replacement therapy planning",
      "Blood pressure and glycemic control targets achievement"
    ]
  },
  "primary_diagnosis_summaries": {
    "key_clinical_findings": [
      {
        "finding": "Proteinuria",
        "supporting_evidence": "Clinical presentation",
        "model_support": 2,
        "reasoning": "Key diagnostic indicator"
      },
      {
        "finding": "Elevated creatinine",
        "supporting_evidence": "Clinical presentation",
        "model_support": 2,
        "reasoning": "Key diagnostic indicator"
      },
      {
        "finding": "Hypertension",
        "supporting_evidence": "Clinical presentation",
        "model_support": 2,
        "reasoning": "Key diagnostic indicator"
      },
      {
        "finding": "Diabetes mellitus",
        "supporting_evidence": "Clinical presentation",
        "model_support": 2,
        "reasoning": "Key diagnostic indicator"
      },
      {
        "finding": "Chronic kidney disease staging",
        "supporting_evidence": "Clinical presentation",
        "model_support": 2,
        "reasoning": "Key diagnostic indicator"
      }
    ],
    "recommended_tests": [
      {
        "test_name": "Serum creatinine and eGFR",
        "test_type": "Laboratory",
        "rationale": "Diagnostic confirmation",
        "priority": "Urgent",
        "model_support": 1,
        "reasoning": "Essential for diagnosis"
      },
      {
        "test_name": "Urine albumin-to-creatinine ratio",
        "test_type": "Laboratory",
        "rationale": "Diagnostic confirmation",
        "priority": "Urgent",
        "model_support": 1,
        "reasoning": "Essential for diagnosis"
      },
      {
        "test_name": "HbA1c",
        "test_type": "Laboratory",
        "rationale": "Diagnostic confirmation",
        "priority": "Urgent",
        "model_support": 1,
        "reasoning": "Essential for diagnosis"
      },
      {
        "test_name": "Complete metabolic panel (electrolytes, BUN)",
        "test_type": "Laboratory",
        "rationale": "Diagnostic confirmation",
        "priority": "Urgent",
        "model_support": 1,
        "reasoning": "Essential for diagnosis"
      },
      {
        "test_name": "Renal ultrasound",
        "test_type": "Laboratory",
        "rationale": "Diagnostic confirmation",
        "priority": "Urgent",
        "model_support": 1,
        "reasoning": "Essential for diagnosis"
      }
    ],
    "immediate_management": [
      {
        "intervention": "Initiate ACE inhibitor or ARB therapy",
        "category": "Medical",
        "urgency": "Immediate",
        "model_support": 1,
        "reasoning": "Critical intervention"
      },
      {
        "intervention": "Optimize glycemic control with target HbA1c <7%",
        "category": "Medical",
        "urgency": "Immediate",
        "model_support": 1,
        "reasoning": "Critical intervention"
      },
      {
        "intervention": "Implement blood pressure control with target <130/80 mmHg",
        "category": "Medical",
        "urgency": "Immediate",
        "model_support": 1,
        "reasoning": "Critical intervention"
      },
      {
        "intervention": "Refer to nephrology for comprehensive management",
        "category": "Medical",
        "urgency": "Immediate",
        "model_support": 1,
        "reasoning": "Critical intervention"
      },
      {
        "intervention": "Initiate dietary sodium and protein restriction",
        "category": "Medical",
        "urgency": "Immediate",
        "model_support": 1,
        "reasoning": "Critical intervention"
      }
    ],
    "medications": [
      {
        "medication_name": "Lisinopril",
        "dosage": "10-40 mg",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Renoprotection and blood pressure control",
        "model_support": 0,
        "reasoning": "Renoprotection and blood pressure control"
      },
      {
        "medication_name": "SGLT2 inhibitor (e.g., Empagliflozin)",
        "dosage": "10-25 mg",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Renoprotection and glycemic control",
        "model_support": 0,
        "reasoning": "Renoprotection and glycemic control"
      },
      {
        "medication_name": "Statin therapy",
        "dosage": "As appropriate",
        "route": "Oral",
        "frequency": "Daily",
        "duration": "Long-term",
        "indication": "Cardiovascular risk reduction",
        "model_support": 0,
        "reasoning": "Cardiovascular risk reduction"
      }
    ]
  },
  "quality_metrics": {
    "total_models_analyzed": 2,
    "consensus_strength": "Strong",
    "successful_responses": 2
  },
  "metadata": {
    "analysis_timestamp": "2025-09-07T17:26:17.341374",
    "orchestrator_model": "deepseek/deepseek-chat-v3.1:free",
    "case_id": "tmpqxoi3p9n",
    "case_title": "Custom Case Analysis",
    "orchestrator_quality": "free_models",
    "quality_disclaimer": "\u26a0\ufe0f This analysis uses free orchestrator models which may provide suboptimal quality compared to premium models. For clinical applications, consider using premium orchestrator models for enhanced accuracy and comprehensive analysis."
  },
  "generated_at": "2025-09-07T17:26:17.341855"
}